 |
Predictive algorithms for adjuvant therapy: transATAC |
Dowsett, Mitch; Salter, Janine; Zabaglo, Lila; Mallon, Elizabeth; Howell, Antony... More
|
2011 |
—
|
|
 |
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial |
Cuzick, Jack; Sestak, Ivana; Baum, Michael; Buzdar, Aman; Howell, Anthony... More
|
2010 |
—
|
|
 |
Effect of body mass index on recurrences in tamoxifen and anastrozole treated women: an exploratory analysis from the ATAC trial |
Sestak, Ivana; Distler, Wolfgang; Forbes, John F.; Dowsett, Mitch; Howell, Anthony... More
|
2010 |
—
|
|
 |
Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen |
Dowsett, Mitch; Cuzick, Jack; Coombes, Charles; Snowdon, Claire; Gnant, Michael... More
|
2010 |
—
|
|
 |
Prediction of risk of distant recurrence using the 21-gene recurrence score in node-negative and node-positive postmenopausal patients with breast cancer treated with anastrozole or tamoxifen: a TransATAC Study |
Dowsett, Mitch; Cuzick, Jack; Howell, Anthony; Bugarini, Roberto; Baehner, Frederick L.... More
|
2010 |
—
|
|
 |
Relationship between quantitative estrogen and progesterone receptor expression and human epidermal growth factor receptor 2 (HER-2) status with recurrence in the arimidex, tamoxifen, alone or in combination trial |
Dowsett, Mitch; Allred, Craig; Bishop, Hugh; Ellis, Ian; Larsimont, Danis... More
|
2008 |
—
|
|